Incannex Healthcare IXHL
NASDAQ IXHL
$3.37 -0.07 (-2.03%)
At close: Aug 20, 2026 · 1:24 PM UTC

Incannex Healthcare (IXHL) Construction in Progress (2023)

Incannex Healthcare (IXHL) posted Construction in Progress of $160000.0 for Q2 2023.

Incannex Healthcare (IXHL) Construction in Progress (2023) Analysis & Trends

Incannex Healthcare has reported Construction in Progress for 1 years, with the latest figure at $160000.0 in Q2 2023.

  • Quarterly Construction in Progress changed N/A year-over-year to $160000.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $160000.0 (changed N/A YoY) and the FY2023 annual result came in at $160000.0, changed N/A from the prior year.
  • Construction in Progress held at $160000.0 in Q2 2023 per IXHL's latest filing.
  • Over five years, Construction in Progress peaked at $160000.0 in Q2 2023 and troughed at $160000.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Haleon 43.89 Bn 42.93 Bn - -
2 Teva Pharmaceutical Industries 43.01 Bn 39.35 Bn 2.15 Bn -
3 Zoetis 31.52 Bn 29.84 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn -
5 United Therapeutics 22.17 Bn 19.51 Bn 683.80 Mn -
6 Viatris 18.73 Bn 17.85 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.51 Bn 15.12 Bn 935.80 Mn -
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn - -
10 Incannex Healthcare 41.61 Mn 41.61 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 160,000.00